全部分类
  • C18 Globotriaosylceramide-d3  (d18:1/18:0-d3)
C18 Globotriaosylceramide-d3  (d18:1/18:0-d3)的可视化放大

C18 Globotriaosylceramide-d3 (d18:1/18:0-d3)

A neuropeptide with diverse biological activities

此产品仅用于科学研究,我们不为任何个人用途提供产品和服务

C18 Globotriaosylceramide-d3  (d18:1/18:0-d3)的二维码
  • 库存: 现货
可选规格
  • 包装
    价格
    促销价
    数量
  • 500ug
    ¥10162.00
    8130.00
    - +
已选 0 0
金额: ¥0.00
首页 收藏
  • 货号: ajcx21918
  • CAS: N/A
  • 别名: N-ω-CD3-Octadecanoyl-ceramide Trihexoside, Galα1-4Galβ1-4Glcβ-Cer(d18:1/18:0) d3, Gb3(d18:1/18:0-d3), Globotriaosylceramide-d3 (d18:1/18:0-d3)
  • 分子式: C54H98D3NO18
  • 分子量: 1055.4
  • 纯度: >98%
  • 溶解度: Chloroform:Methanol (2:1): soluble,DMSO: soluble
  • 储存: Store at -20°C
  • 库存: 现货

Background

C18 Globotriaosylceramide-d3 is intended for use as an internal standard for the quantification of C18 globotriaosylceramide by GC- or LC-MS. C18 globotriaosylceramide is an endogenous sphingolipid that accumulates in the brain, heart, kidney, liver, lung, and spleen in a mouse model of Fabry disease, a lysosomal storage disorder characterized by a deficiency in the enzyme α-galactosidase A.1 [Matreya, LLC. Catalog No. 1537]



1.Kamani, M.A., Proven?al, P., Boutin, M., et al.Glycosphingolipid storage in Fabry mice extends beyond globotriaosylceramide and is affected by ABCB1 depletionFuture Sci. OA.2(4)FS0147(2016)

没有评价数据

温馨提示 ×
商品已成功加入购物车!
购物车共 0 件商品
去购物车结算